WallStreetZenWallStreetZen

NYSE: EW
Edwards Lifesciences Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for EW

Based on 11 analysts offering 12 month price targets for Edwards Lifesciences Corp.
Min Forecast
$57.00-35.67%
Avg Forecast
$89.55+1.06%
Max Forecast
$105.00+18.5%

Should I buy or sell EW stock?

Based on 11 analysts offering ratings for Edwards Lifesciences Corp.
Buy
Strong Buy
4 analysts 36.36%
Buy
2 analysts 18.18%
Hold
4 analysts 36.36%
Sell
1 analysts 9.09%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their EW stock forecasts and price targets.

EW stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-15
lockedlocked$00.00+00.00%2024-04-11
lockedlocked$00.00+00.00%2024-04-04
lockedlocked$00.00+00.00%2024-04-03
lockedlocked$00.00+00.00%2024-03-21
Oppenheimer
Bottom 7%
7
BuyMaintains$100.00+12.85%2024-03-18
Stifel Nicolaus
Top 8%
93
HoldMaintains$83.00-6.33%2024-02-07
Wells Fargo
Top 12%
89
Strong BuyUpgrades$94.00+6.08%2024-02-02
Truist Securities
Top 6%
95
Strong BuyMaintains$84.00-5.20%2023-12-22
Wolfe Research
Top 19%
82
SellDowngrades$57.00-35.67%2023-11-28

1 of 2

Forecast return on equity

Is EW forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.42%

Forecast return on assets

Is EW forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

EW revenue forecast

What is EW's revenue in the next 3 years based on estimates from 12 analysts?
Avg 1 year Forecast
$6.5B+8.48%
Avg 2 year Forecast
$7.1B+18.98%
Avg 3 year Forecast
$7.8B+30.29%
EW's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EW earnings growth forecast

How is EW forecast to perform vs Medical Devices companies and vs the US market?
Company
26.57%
Industry
25.23%
Market
21.81%
EW's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
EW's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
EW's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

EW revenue growth forecast

How is EW forecast to perform vs Medical Devices companies and vs the US market?
Company
9.16%
Industry
8.29%
Market
10.08%
EW's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EW's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EW vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
EW$88.61$89.55+1.06%Buy
DXCM$137.87$149.71+8.59%Strong Buy
ZBH$121.17$133.20+9.93%Hold
ALGN$313.78$331.33+5.59%Buy
STE$202.80$239.60+18.15%Buy
View Top Medical Device Stocks

Edwards Lifesciences Stock Forecast FAQ

Is Edwards Lifesciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NYSE: EW) stock is to Buy EW stock.

Out of 11 analysts, 4 (36.36%) are recommending EW as a Strong Buy, 2 (18.18%) are recommending EW as a Buy, 4 (36.36%) are recommending EW as a Hold, 1 (9.09%) are recommending EW as a Sell, and 0 (0%) are recommending EW as a Strong Sell.

If you're new to stock investing, here's how to buy Edwards Lifesciences stock.

What is EW's revenue growth forecast for 2024-2026?

(NYSE: EW) Edwards Lifesciences's forecast annual revenue growth rate of 9.16% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Edwards Lifesciences's revenue in 2024 is $6,004,800,000.On average, 12 Wall Street analysts forecast EW's revenue for 2024 to be $3,914,807,623,000, with the lowest EW revenue forecast at $3,880,988,151,000, and the highest EW revenue forecast at $3,969,605,000,000. On average, 12 Wall Street analysts forecast EW's revenue for 2025 to be $4,293,891,378,000, with the lowest EW revenue forecast at $4,204,596,000,000, and the highest EW revenue forecast at $4,390,906,000,000.

In 2026, EW is forecast to generate $4,702,128,441,000 in revenue, with the lowest revenue forecast at $4,535,747,000,000 and the highest revenue forecast at $4,823,626,000,000.

What is EW's forecast return on assets (ROA) for 2024-2027?

(NYSE: EW) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of N/A.

What is EW's Price Target?

According to 11 Wall Street analysts that have issued a 1 year EW price target, the average EW price target is $89.55, with the highest EW stock price forecast at $105.00 and the lowest EW stock price forecast at $57.00.

On average, Wall Street analysts predict that Edwards Lifesciences's share price could reach $89.55 by Apr 15, 2025. The average Edwards Lifesciences stock price prediction forecasts a potential upside of 1.06% from the current EW share price of $88.61.

What is EW's forecast return on equity (ROE) for 2024-2027?

(NYSE: EW) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.